In addition, CITE-seq analysis also showed an increase in CCL22 expression in CD81+migcDC1s upon Flt3L treatment and could together with the CCL22 expression observed in migDCs be the cause of the increased CCL22 observed in the E0771 tumor supernatants. The gene discussed is CCL22; the disease is neoplasm.